Riskpilot← Back to searchSign inGet full accessMEDEOR AS
ASActiveOrg 923850503Skogsnaret 15, 3150 TolvsrødWholesale of pharmaceutical and medical goods · NACE 4646Est. 20191 employees
Revenue 2024
NOK 5,8M
+49% vs 2023
EBITDA margin
12.5%
+101% vs 2023
Equity ratio
18.0%
Financial strength
Net profit 2024
NOK 270K
+910% vs 2023
| Revenue | NOK 5,8M | +49% |
| EBITDA | NOK 719K | +101% |
| Net profit | NOK 270K | +910% |
| Total assets | NOK 3,1M | +28% |
| Equity | NOK 565K | -14% |
| Employees | 1 | — |
Legal name
MEDEOR AS
Org number
923850503
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. november 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Importere og selge medisinsk utstyr til norske sykehus, fortrinnsvis innen endoskopiske prosedyrer og endoskopisk kirurgi. Handel i inn- og utland samt annen virksomhet forbundet med dette, herunder deltakelse i andre selskaper. Kjøp og salg i inn- og utland herunder import og eksport samt annen virksomhet forbundet med dette, herunder deltakelse i andre selskaper.
Address
Skogsnaret 15, 3150 Tolvsrød
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 373 | 2 265 | 2 883 | 3 871 | 5 753 |
| Staff expenses | −50 | −95 | −293 | −334 | −753 |
| EBITDA | 314 | 611 | 483 | 358 | 719 |
| Depreciation & amort. | −0 | −0 | −0 | −218 | −264 |
| EBIT | 314 | 611 | 483 | 140 | 455 |
| Net financials | −8 | −12 | −26 | −93 | −91 |
| Profit before tax | 306 | 599 | 457 | 46 | 364 |
| Tax | 66 | 156 | 104 | 20 | 94 |
| Net profit | 240 | 443 | 353 | 27 | 270 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 638 | 1 111 | 1 411 | 2 445 | 3 135 |
| Equity | 263 | 410 | 763 | 659 | 565 |
| Long-term debt | 0 | 0 | 0 | 1 224 | 1 113 |
| Short-term debt | 375 | 702 | 648 | 562 | 1 458 |
| Total debt | 375 | 702 | 648 | 1 786 | 2 571 |
EBITDA margin
12.5%
This company
15.8%
Market median
-21% vs market
20202024
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20202024
Return on equity
47.7%
This company
18.4%
Market median
+159% vs market
20202024
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20202024
Asset turnover
1.83×
This company
1.12×
Market median
+63% vs market
20202024
Debt / equity
4.55×
This company
0.62×
Market median
-634% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GG Chief Executive Officer | Chief Executive Officer | 2019 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Think Holding As
MEDEOR AS Board members of MEDEOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnar Gjeldnes | Chief Executive Officer | 0 companies |
| Poyan Emamdost Myhre | Chairman | 0 companies |
| Mari Emamdost Myhre | Board of Directors | 0 companies |